Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODM-216 in Advanced Solid Tumors
NCT07805252Phase 2Recruiting
- Sponsor
- Orion Corporation
- Start
- Sep 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of ODM-216 in solid tumor (advanced stage), sponsored by Orion Corporation. Started Sep 2026; status: recruiting.
02
Drugs
ODM-216
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07805252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07805252.